FIELD: biotechnology, medicine, endocrinology, biochemistry, pharmacy.
SUBSTANCE: invention proposes using PIM-3 as agent for identifying medicinal agents used against diabetes mellitus type 2. Using the invention provides medicinal agents against diabetes mellitus type 2 that effect on the PIM-3 expression level. Invention can be used in pharmaceutical industry.
EFFECT: valuable medicinal properties of agent.
3 cl, 11 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OLIGONUCLEOTIDE SEQUENCES AIMED AT THE TRANSCRIPTION FACTOR TSC22D4, FOR TREATING INSULIN RESISTANCE | 2016 |
|
RU2723091C2 |
| METHODS FOR PREDICTING PROSTATE CANCER | 2016 |
|
RU2760577C2 |
| SIRNA AND THEIR USE IN METHODS AND COMPOSITIONS FOR INHIBITING NRARP GENE EXPRESSION | 2016 |
|
RU2738971C2 |
| USE OF ZSCAN4 FOR HUMAN CELL REJUVENATION | 2014 |
|
RU2801207C2 |
| COMPOSITIONS, DIAGNOSTIC TECHNIQUES AND METHOD OF TREATING RENAL DISORDERS IN DOGS | 2010 |
|
RU2546016C2 |
| GENE (LBFL313) FAMILY ASSOCIATED WITH MALIGNANT GROWTH OF PANCREAS | 2007 |
|
RU2432399C2 |
| ANTIBODY AGAINST TUMOR-SPECIFIC ANTIGENS AS TARGET | 2004 |
|
RU2345090C2 |
| AGENTS FOR TREATMENT OF CLAUDIN EXPRESSING CANCER DISEASES | 2013 |
|
RU2678127C2 |
| FACTOR 11 EXPRESSION MODULATION | 2009 |
|
RU2535964C2 |
| MORPHOGENE BONE PROTEINS (BMP), BMP RECEPTORS AND BINDING BMP PROTEINS AND THEIR APPLICATION FOR DIAGNOSTICS AND GLAUCOMA TREATMENT | 2002 |
|
RU2336902C2 |
